We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the dev... Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis. Show more
Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.57 | -53.5836177474 | 2.93 | 2.95 | 1.25 | 7973109 | 1.75808702 | CS |
4 | 0.11 | 8.8 | 1.25 | 4.28 | 1.02 | 4433477 | 2.00495984 | CS |
12 | -0.01 | -0.729927007299 | 1.37 | 4.28 | 0.882 | 1796760 | 1.86434001 | CS |
26 | 0 | 0 | 1.36 | 4.28 | 0.6 | 1086786 | 1.69334771 | CS |
52 | -2.32 | -63.0434782609 | 3.68 | 5.67 | 0.6 | 728362 | 2.12670198 | CS |
156 | -1.64 | -54.6666666667 | 3 | 9.2499 | 0.53 | 606333 | 2.93239051 | CS |
260 | -8.1 | -85.6236786469 | 9.46 | 9.61 | 0.53 | 564009 | 3.904752 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions